ET
VIR icon

Entropy Technologies’s Vir Biotechnology VIR Stock Holding History

Entropy Technologies’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$216K Buy
+21,171
New +$201K 0.01% 870
2024
Q3 		– Sell
-12,573
Closed -$112K – 938
2024
Q2 		$112K Buy
+12,573
New +$121K 0.01% 628

Other funds holding VIR

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
AVM
Arch Venture Management Chicago, Illinois $1.1B AUM 356.62% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
GP
GSK plc London $602M AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $90.7B AUM 77.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Entropy Technologies's VIR Position: Q2 2026 in Review

Entropy Technologies opened a new position in Vir Biotechnology (VIR) in Q2 2026: 21,171 shares worth $216K. The stake represents 0.01% of the portfolio and ranks #870 among its holdings. This is a return to the name: Entropy Technologies previously reported a position in VIR as recently as Q2 2024.

Entropy Technologies first reported a position in VIR in Q2 2024 and has held it in 2 quarters since. 237 funds tracked by Wall St. Rank hold VIR as of Q2 2026.

  • Entropy Technologies held 21,171 shares of Vir Biotechnology worth $216K as of Q2 2026.
  • Vir Biotechnology was a new Entropy Technologies position in Q2 2026.
  • Vir Biotechnology made up 0.01% of Entropy Technologies's portfolio in Q2 2026, its #870 holding.
  • Entropy Technologies first reported a position in Vir Biotechnology in Q2 2024 and has held it in 2 quarters since.
  • 237 funds tracked by Wall St. Rank held Vir Biotechnology as of Q2 2026.

Based on Entropy Technologies's 13F filing for Q2 2026, filed 13 Aug 2026.